Self-supervised learning offers a compelling approach for medical imaging, where labeled data are scarce and acquisition costs are high. We present COJEPA, a self-supervised framework for volumetric brain MRI that combines a joint-embedding predictive architecture (JEPA) with a contrastive loss (CO), targeting two complementary properties: local predictivity and global discriminability. The model is trained without labels on T1-weighted structural MRI from two cohorts (HCP-YA and AABC, $N{=}2286$, ages 22 to 90), extending I-JEPA to 3D with foreground-aware block masking, a hierarchical convolutional patch embedding, and world-space sinusoidal positional encodings. We evaluate all three objectives across zero-shot twin retrieval, brain tumor segmentation (BraTS 2024), and age regression (OpenBHB). COJEPA achieves the best monozygotic twin recall at rank@1 (0.84), the best finetuning age MAE (2.55 years on OpenBHB 3.0T), and matches CO on BraTS whole-tumor Dice, demonstrating that the combined objective yields representations that are simultaneously discriminative and locally structured.
We study the modality gap in CLIP-style dual-encoder contrastive learning, where image and text embeddings remain misaligned despite being trained in a shared space. We argue that the gap is induced by a failure of the InfoNCE formulation with independent encoders. We conduct a u…
Foundation models provide powerful representations for brain MRI analysis, but their predictions remain difficult to interpret in anatomically meaningful terms. Clinical assessment of brain MRI is commonly organized around anatomically defined structures and regional abnormalitie…
Multimodal models such as CLIP learn a shared embedding space for cross-modal retrieval, but continual adaptation to sequentially arriving data can disrupt the cross-modal alignment acquired from earlier phases. Conventional continual-learning methods return a single checkpoint,…
In patients with breast cancer, pathological complete response (pCR) has been established as a clinically meaningful surrogate marker for long-term outcomes. While commonly treated with neoadjuvant chemotherapy (NACT), effective treatment decision-making remains challenging, as t…
Introduction: Objective neuroimaging biomarkers may improve Parkinson's disease motor assessment by capturing brain variation not directly observable from clinical examination. We used interpretable machine learning to predict current motor severity, measured by MDS-UPDRS Part II…
Images tell us what a scene looks like, but rarely what it would feel like to be there. While recent datasets pair visual scenes with electronic-nose measurements, aligning smell signals with images remains challenging because many olfactory cues arise from contextual environment…